Biox Nexevo

OEM Manufacturing · Dosage Forms

The Format Decision That Shapes Everything After It

Non-pill formats have quietly overtaken tablets and capsules in total market share. Here's what that shift means for your MOQ, cost per unit, and which format actually fits your active ingredient.

Reviewed by Biox Nexevo Regulatory Affairs Updated 2 Sep 2026 8 min read

Market share shift

65%

Non-pill formats' share of the supplement market

Formats available 6
Lowest MOQ format Capsules
Fastest-growing Gummies
Find My Format
Industry context: Nutraceuticals World · NBJ · Grand View Research

The dosage form you choose isn't a packaging decision made at the end of development — it's a formulation decision that shapes bioavailability, manufacturing cost, and how consumers actually experience the product. And the ground has shifted: non-pill formats, led by gummies, now make up roughly 65% of total supplement market share, a trend reshaping how brands should think about format from day one.

Format Is a Formulation Decision, Not Packaging

Start with the active ingredient, not the trend. Fat-soluble actives generally perform best in softgels or oil-suspended capsules. High-dose actives that would require an unreasonably large capsule are better suited to powder or liquid formats. If shelf appeal and social-commerce relevance matter more than clinical dosing precision, gummies deliver strong visibility — but need careful formulation to hit effective doses without excessive sugar or gelling-agent bulk.

Market shift

Non-Pill Rising

~65% of total supplement market share

Still leading

Tablets

Largest single-format share, easiest regulatory path

Fastest growing

Gummies

Highest projected CAGR of any format

Term to know — MOQ

Minimum Order Quantity — the smallest batch size a manufacturer will produce per run. MOQ varies significantly by format: capsules typically start around 500–2,500 units for private label formulas, while gummies and softgels carry higher minimums due to specialised equipment and mould setup costs.

Halal Considerations by Format

Capsule shells and gummy bases are the two formats where halal sourcing most commonly trips up brands — conventional gelatin in both is frequently derived from non-halal sources unless specifically sourced otherwise. Working with a halal-native manufacturer means shell and gelling-agent sourcing is halal-verified by default, rather than a separate supplier search your team has to run mid-project.

The Six Formats Compared

Each format trades off differently across cost, MOQ, and what it can actually deliver.

Lowest MOQ

Capsules

Precise dosing, halal-verified shells, most versatile format for a first launch.

Gummies

Fastest-growing format, strong shelf appeal, higher MOQ and per-unit cost.

Powders

Best for high-dose actives — protein, collagen, pre/probiotic blends.

Liquids / Shots

Fast absorption, popular for vitamin blends and functional beverages.

Softgels

Best for fat-soluble actives — omega-3s, vitamin D — higher MOQ than capsules.

Tablets

Still the largest single-format share, cost-efficient at scale, easiest regulatory path.

Real Cost & MOQ Ranges

Figures vary by formulation and supplier, but these ranges reflect what brands actually see at quote stage.

Format Typical MOQ Cost per Unit
Capsules500–5,000 unitsUSD 0.03–0.10
TabletsMid-rangeUSD 0.03–0.10
PowdersMid-rangeVaries by active
LiquidsMid-rangeVaries by active
SoftgelsHigherUSD 0.05–0.20
GummiesHighestUSD 0.05–0.20+

Common mistake

Choosing gummies for shelf appeal without checking whether your active ingredient can actually hit an effective dose within a gummy's practical serving size — some actives simply don't fit the format without excessive sugar or serving count.

How to Actually Choose

If capital efficiency for a first launch matters more than format novelty, starting with capsules or tablets — the lowest MOQ, lowest cost-per-unit formats — and expanding into gummies once the brand is established is a common, sensible sequencing. If your active ingredient is fat-soluble, softgels are usually non-negotiable regardless of MOQ preference. If dose size is simply too large for a capsule, powders or liquids become the practical answer.

The right sequence is: confirm what the active ingredient physically requires first, then weigh format trend and MOQ tolerance within whatever options remain — not the other way around.

The Format Decision Process

1

Assess the Active

Check solubility, dose size, and stability requirements first.

2

Weigh MOQ & Budget

Match remaining viable formats against capital tolerance.

3

Confirm Feasibility

Validate the final choice with your manufacturer before formulation.

How Biox Nexevo Handles This

All six formats, on halal-certified lines, from a 500-unit minimum.

Our formulation team advises on the right format during the brand brief stage — before formulation trials begin — so you're not redesigning packaging around a format that doesn't suit your active ingredients.

Frequently Asked Questions

Capsules typically support the lowest MOQs — around 500 to 2,500 bottles for private label formulas and 1,500 to 5,000 for custom formulations. Gummies and softgels carry the highest minimums due to equipment setup costs.

Non-pill formats, led by gummies, now account for approximately 65% of total supplement market share, with gummies specifically projected to grow at the fastest rate of any format going forward.

Tablets and capsules are the most cost-effective, typically USD 0.03 to 0.10 per unit. Softgels and gummies run higher, roughly USD 0.05 to 0.20 per unit or more, due to encapsulation equipment and flavouring complexity.

Start with the active ingredient's properties — fat-soluble actives suit softgels, high-dose actives suit powders or liquids — then weigh MOQ tolerance and target market trend against that constraint.

Some can, though many contract manufacturers specialise in one or two formats where their equipment and expertise are strongest. Ask directly which formats a manufacturer routinely produces at your target volume, not just which they list as capabilities.

Not sure which format fits your formula? Let's talk it through.

Talk to Us on WhatsApp

Sources: Nutraceuticals World and NBJ industry market share data; Grand View Research Dietary Supplement Contract Manufacturing Market report. Cost and MOQ figures are industry-typical ranges — confirm current pricing and minimums directly with your manufacturing partner before finalising a format.

Continue Your Research

Related manufacturing guides